Last reviewed · How we verify
NCT05788614: RV-RSA
Retroversion in Reverse Shoulder Arthroplasty
NA trial testing Reverse shoulder arthroplasty in Shoulder Osteoarthritis in 90 participants. Currently enrolling.
30 June 2026
Quick facts
| Lead sponsor | Hospital Universitario Reina Sofia de Cordoba |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 30 June 2022 |
| Primary completion | 30 June 2026 |
| Estimated completion | 30 June 2026 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Reverse shoulder arthroplasty
Conditions studied
- Shoulder Osteoarthritis — all drugs for Shoulder Osteoarthritis →
Sponsor
Hospital Universitario Reina Sofia de Cordoba
Who can join
60 and older, any sex, with Shoulder Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to compare function in reverse shoulder arthroplasty (RSA) using two different degrees of humeral retroversion (RV). The main question it aims to answer is: • Does external rotation improves when using a higher retroversion? Participants will randomly receive a 0 degree or 30 degree RV for their RSA. They will be followed for two years and clinical outcomes will be recorded and analyzed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05788614
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Shoulder Osteoarthritis
Currently open trials in the same condition.
- NCT07347054 — Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Shoulder Osteoarthritis(OA) · NA · recruiting
- NCT06381791 — CBD for Pain Following Orthopedic Shoulder Surgery · Phase 1, PHASE2 · recruiting
- NCT06319911 — AETOS Shoulder System · recruiting
- NCT06025448 — Is MIO-RSA Noninferior to BIO-RSA When it Comes to Mechanical Implant Stability? · NA · recruiting
- NCT06025331 — Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA? · NA · recruiting
Other Hospital Universitario Reina Sofia de Cordoba trials
Trials by the same sponsor.
- NCT07175883 — Comparison of Postoperative Pain in Primary Cemented Total Knee Arthroplasty With or Without Drain · NA · completed
- NCT04116151 — Effectiveness of a Cream for Treatment of Dermatitis in Patients Whith Breast Cancer · NA · completed
- NCT05468814 — Comparison of Two Techniques for the Treatment of Carpal Tunnel Syndrome · NA · completed
- NCT04811729 — Effectiveness of an Intervention in Patients With Excessive Alcohol Consumption · NA · completed
- NCT03762044 — New Therapeutic Approach in Upper Limb Lymphedema Secondary to Breast Cancer: Activity-oriented Proprioceptive Antiedema · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05788614 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Universitario Reina Sofia de Cordoba
- Last refreshed: 29 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05788614.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing